Biotech

All Articles

Takeda faucets new head of US oncology company-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, firings and also ...

Vertex, hammered through AATD again, goes down 2 assets on discard stack

.Tip's attempt to deal with a rare hereditary disease has reached yet another trouble. The biotech t...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter incomes report wasn't short of huge updates. The business welcom...

Galapagos pauses CAR-T tissue therapy hearing over Parkinsonism scenario

.Galapagos has paused application in a trial of a BCMA-directed CAR-T tissue therapy, pushing the br...

James Wilson leaving Penn to release pair of brand new biotechs

.After much more than three decades, gene treatment trendsetter James Wilson M.D., Ph.D., is actuall...

3 biotechs try to trump the summer season warmth by shedding personnel

.As biotechs try to turn a new page in August, a minimum of three companies have actually lost staff...

venBio elevates $528M for 5th lifestyle scientific researches VC fund

.Expert financial backing company venBio has elevated yet another half a billion dollars to buy biot...

Otsuka pays $800M for Jnana as well as its clinical-stage PKU drug

.Otsuka Drug has actually gotten Boston-based Jnana Therapeutics for $800 million so the Oriental bi...

FibroGen lays off 75% of US personnel as property fails 2 even more trials

.FibroGen is significantly restructuring its organization, giving up 75% of its own united state wor...

Tracon wane weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually decided to unwind operations weeks after an injectable immune s...